dronabinol has been researched along with Schizophrenia in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.59) | 18.7374 |
| 1990's | 3 (4.76) | 18.2507 |
| 2000's | 15 (23.81) | 29.6817 |
| 2010's | 36 (57.14) | 24.3611 |
| 2020's | 8 (12.70) | 2.80 |
| Authors | Studies |
|---|---|
| Kayir, H; Khokhar, JY; McCunn, P; Ruffolo, J | 1 |
| Bhattacharya, K; Chaudhary, RK; Dwivedi, PS; Harish, DR; Khanal, P; Patil, BM; Patil, VS; Roy, S; Shrivastava, AK; Singh, L | 1 |
| Giuffrida, A; Martinez, AA; Seillier, A | 1 |
| Baldasso, GM; Bicca, MA; Capasso, R; Dutra, RC; Gonçalves, ECD; Paes, RS | 1 |
| Barrera-Conde, M; Canela, EI; Casadó, V; Cordomi, A; Correll, CU; Cuenca-Royo, A; de la Torre, R; Fernández-Avilés, C; Galindo, L; Guinart, D; Moreno, E; Pardo, L; Pérez, EJ; Pérez, V; Robledo, P | 1 |
| Bleich, S; Frieling, H; Groh, A; Heese, A; Jahn, K; Kebir, O; Krebs, MO | 1 |
| Arosio, B; D'Addario, C; Dell'Osso, B; Di Bartolomeo, M; Di Marzo, V; Drago, F; Iannotti, FA; Kuchar, M; Laudani, S; Maccarrone, M; Maurel, OM; Mechoulam, R; Micale, V; Pekarik, V; Piscitelli, F; Ruda-Kucerova, J; Salomone, S; Stark, T; Vismara, M; Wotjak, CT | 1 |
| Barr, MS; George, TP; Goodman, MS; Herman, Y; Kiang, M; Kish, SJ; Rabin, RA; Remington, G; Zakzanis, KK | 1 |
| Callesen, MB; Feldstein Ewing, SW; Rømer Thomsen, K | 1 |
| Csernansky, JG; Dong, H; Meltzer, HY; Neugebauer, NM; Rodríguez, G; Yao, KL | 1 |
| Brunette, MF; Fischer, AS; Green, AI; Henricks, AM; Khokhar, JY; Roth, RM; Whitfield-Gabrieli, S | 1 |
| Jobson, CEL; Kramar, CP; Laviolette, SR; Moura, K; Renard, J; Rushlow, WJ; Szkudlarek, HJ | 1 |
| Barry, G; Bitar, M; Brennand, KJ; Guennewig, B; Hanks, J; Hurd, YL; Kaczorowski, DC; O'Brien, EA; Obiorah, I; Roussos, P | 1 |
| Endepols, H; Graf, R; Leweke, FM; Pahlisch, F; Rohleder, C | 1 |
| Drago, F; Drazanova, E; Kratka, L; Kuchar, M; Maryska, M; Micale, V; Ruda-Kucerova, J; Starcuk, Z; Stark, T | 1 |
| Herman, MS; Rosenzweig, I; Vukadinovic, Z | 1 |
| James, A; James, C; Thwaites, T | 1 |
| Bhattacharyya, S; Bossong, MG; Jansma, JM; Ramsey, NF | 1 |
| Smucny, J; Stevens, KE; Tregellas, JR | 1 |
| Bouchard, C; Gallo, A; Rompré, PP | 1 |
| Brunette, MF; Fischer, AS; Green, AI; Roth, RM; Whitfield-Gabrieli, S | 1 |
| Bouchard, C; Ducrot, C; Fortier, E; Gallo, A; Rompré, PP | 1 |
| Cascio, MG; Marini, P; Parolaro, D; Pertwee, RG; Zamberletti, E | 1 |
| Degenhardt, L; Hall, W | 1 |
| Hamilton, I | 1 |
| Cressey, D | 1 |
| Hill, M | 1 |
| Aguilar, DD; Giuffrida, A; Lodge, DJ | 1 |
| Lu, HC; Mackie, K | 1 |
| Cortes-Briones, JA; Hajós, M; Skosnik, PD | 1 |
| Osborne, AL; Solowij, N; Weston-Green, K | 1 |
| Laviolette, SR; Norris, C; Renard, J; Rushlow, W | 1 |
| Di Forti, M; Henquet, C; Kuepper, R; Morrison, P; Murray, RM | 1 |
| di Forti, M; Luzi, S; Morrison, PD; Murray, RM; Powell, J | 1 |
| Kawohl, W; Rössler, W | 1 |
| Karajgi, B; McCarthy, R; Schwarcz, G | 1 |
| Arnold, JC; Chesworth, R; Huang, XF; Karl, T; Long, LE; McGregor, IS | 1 |
| Arnold, JC; Chesworth, R; Karl, T; Long, LE | 1 |
| Bossong, MG; Niesink, RJ | 1 |
| Arnold, JC; Boucher, AA; Huang, X; Hunt, GE; Karl, T; McGregor, IS; Micheau, J | 1 |
| Bourdel, MC; Dervaux, A; Krebs, MO; Laqueille, X | 1 |
| Dekker, N; Koeter, MW; Meijer, CJ; Meijer, JH; Quee, PJ; van Beveren, NJ | 1 |
| Ashton, CH; Moore, PB | 1 |
| Heekeren, K | 1 |
| Bossong, MG; Jager, G; Jansma, JM; Kahn, RS; Oudman, E; Ramsey, NF; Saliasi, E; van Hell, HH | 1 |
| Arnold, JC; Boucher, AA; Karl, T | 1 |
| Deiana, S | 1 |
| Evins, AE; Green, AI; Kane, JM; Murray, RM | 1 |
| Bradbury, R; Copolov, DL; Dean, B | 1 |
| Kalant, H | 1 |
| Abi-Saab, WM; Braley, G; Cooper, TB; D'Souza, DC; Doersch, A; Forselius-Bielen, K; Gueorguieva, R; Krystal, JH; Madonick, S | 1 |
| Baur, K; Rosburg, T; Rudolph, N; Sauer, H; Smesny, S | 1 |
| Arnold, JC; Boucher, AA; Duffy, L; Karl, T; Micheau, J; Schofield, PR | 1 |
| Castle, D | 1 |
| Grech, A | 1 |
| Henquet, C; Van Os, J | 1 |
| Anghelescu, I; Jockers-Scherubl, M; Regen, F; Schindler, F | 1 |
| Koethe, D; Leweke, FM | 1 |
| Bowers, MB; Druss, B; Imirowicz, R; Mazure, CM | 1 |
| Doyle, E; Spence, AA | 1 |
| Calcedo-Ordoñez, A; Martinez-Arevalo, MJ; Varo-Prieto, JR | 1 |
| Bradbury, R; Copolov, D; Dean, B; Scarr, E; Sundram, S | 1 |
| Lachance, R | 1 |
16 review(s) available for dronabinol and Schizophrenia
| Article | Year |
|---|---|
Terpenoids, Cannabimimetic Ligands, beyond the
Topics: Alzheimer Disease; Anxiety; Bicyclic Monoterpenes; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cognitive Dysfunction; Dronabinol; Humans; Inflammatory Bowel Diseases; Neuralgia; Neuroprotective Agents; Nootropic Agents; Schizophrenia; Sesquiterpenes; Terpenes | 2020 |
Cannabis, psychosis and the thalamus: a theoretical review.
Topics: Animals; Calcium Channels, T-Type; Cannabinoids; Cannabis; Cerebral Cortex; Dronabinol; Electroencephalography; Hallucinogens; Humans; Neural Pathways; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thalamus | 2013 |
The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review.
Topics: Adolescent; Brain; Cannabis; Cognition; Dronabinol; Health; Humans; Marijuana Abuse; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuropsychological Tests; Parietal Lobe; Psychometrics; Schizophrenia; Sex Characteristics | 2013 |
Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
Topics: Animals; Brain; Cannabinoid Receptor Agonists; Cognition; Dopamine; Dronabinol; Endocannabinoids; Humans; Neuroimaging; Schizophrenia | 2014 |
An Introduction to the Endogenous Cannabinoid System.
Topics: Arachidonic Acids; Cannabinoid Receptor Agonists; Dronabinol; Endocannabinoids; Glycerides; Humans; Neuronal Plasticity; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Schizophrenia | 2016 |
It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.
Topics: Attention; Brain; Cannabinoid Receptor Agonists; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Marijuana Smoking; Memory, Short-Term; Psychomotor Performance; Psychotic Disorders; Schizophrenia | 2016 |
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Topics: Antipsychotic Agents; Cannabidiol; Cognition; Dronabinol; Humans; Schizophrenia | 2017 |
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments.
Topics: Cannabidiol; Dopamine; Dronabinol; Humans; Schizophrenia | 2017 |
Gene-environment interplay between cannabis and psychosis.
Topics: Alleles; Animals; Catechol O-Methyltransferase; Disease Models, Animal; Dronabinol; Epigenesis, Genetic; Gene Expression; Genotype; Humans; Individuality; Marijuana Abuse; Neuropsychological Tests; Psychiatric Status Rating Scales; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Schizophrenic Psychology; Social Environment; Stress, Psychological | 2008 |
What is the mechanism whereby cannabis use increases risk of psychosis?
Topics: Abnormalities, Drug-Induced; Cannabidiol; Cannabinoid Receptor Modulators; Dopamine; Dronabinol; Humans; Marijuana Smoking; Paranoid Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia | 2008 |
[Cannabis and Schizophrenia: new findings in an old debate].
Topics: Causality; Comorbidity; Cross-Sectional Studies; Dronabinol; Humans; Incidence; Marijuana Abuse; Psychoses, Substance-Induced; Risk; Schizophrenia | 2008 |
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
Topics: Adolescent; Brain; Cannabinoid Receptor Modulators; Cannabis; Dronabinol; Humans; Marijuana Abuse; Models, Neurological; Nerve Net; Neurobiology; Neurotransmitter Agents; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Risk Factors; Schizophrenia; Synapses | 2010 |
Endocannabinoid system dysfunction in mood and related disorders.
Topics: Anxiety; Bipolar Disorder; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Depression; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Mood Disorders; Pain; Receptors, Cannabinoid; Schizophrenia; Suicide | 2011 |
[Does cannabis use lead to schizophrenia?].
Topics: Brain; Cannabidiol; Causality; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Dopamine; Dronabinol; Humans; Marijuana Abuse; Neuropsychological Tests; Psychoses, Substance-Induced; Risk; Schizophrenia; Switzerland | 2011 |
Adverse effects of cannabis on health: an update of the literature since 1996.
Topics: Accidents, Traffic; Automobile Driving; Cannabis; Cardiovascular Diseases; Cognition Disorders; Cohort Studies; Dronabinol; Humans; Longitudinal Studies; Marijuana Abuse; Marijuana Smoking; Neurotoxicity Syndromes; Psychomotor Performance; Public Health; Respiratory Tract Diseases; Risk; Schizophrenia | 2004 |
Cannabis and psychiatric disorders: it is not only addiction.
Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction | 2008 |
3 trial(s) available for dronabinol and Schizophrenia
| Article | Year |
|---|---|
Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
Topics: Adult; Antipsychotic Agents; Dronabinol; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Psychometrics; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Effects of δ9-tetrahydrocannabinol on human working memory function.
Topics: Adolescent; Adult; Cerebellum; Cerebral Cortex; Cross-Over Studies; Dronabinol; Functional Neuroimaging; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Recognition, Psychology; Schizophrenia; Young Adult | 2012 |
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
Topics: Adult; Akathisia, Drug-Induced; Arousal; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endocrine System; Female; Humans; Injections, Intravenous; Male; Mental Recall; Middle Aged; Motor Activity; Neuropsychological Tests; Perception; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Verbal Learning | 2005 |
44 other study(ies) available for dronabinol and Schizophrenia
| Article | Year |
|---|---|
The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
Topics: Adolescent; Animals; Cannabinoids; Cannabis; Cognition; Dronabinol; Hallucinogens; Humans; Schizophrenia | 2023 |
The marijuana-schizophrenia multifaceted nexus: Connections and conundrums towards neurophysiology.
Topics: Cannabis; Dronabinol; Endocannabinoids; Humans; Molecular Docking Simulation; Neurophysiology; Receptors, Cannabinoid; Schizophrenia | 2023 |
Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model.
Topics: Animals; Arachidonic Acids; Disease Models, Animal; Dronabinol; Endocannabinoids; Glycogen Synthase Kinase 3 beta; Male; Motor Activity; Neurons; Phencyclidine; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Schizophrenia; Signal Transduction; Ventral Tegmental Area | 2020 |
Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.
Topics: Adult; Antipsychotic Agents; Cannabinoid Receptor Agonists; Cells, Cultured; Clozapine; Cross-Sectional Studies; Dronabinol; Female; Humans; Male; Marijuana Use; Neuroepithelial Cells; Olfactory Receptor Neurons; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A; Schizophrenia; Young Adult | 2020 |
Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.
Topics: Adult; Calcium-Binding Proteins; Cannabinoid Receptor Agonists; DNA Methylation; Dronabinol; Female; Humans; Male; Nerve Tissue Proteins; Neural Cell Adhesion Molecules; Neuregulin-1; Promoter Regions, Genetic; Schizophrenia; tau Proteins | 2021 |
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Topics: Animals; Behavior, Animal; DNA Methylation; Dronabinol; Female; Gene Expression Regulation; Humans; Male; Maternal-Fetal Exchange; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; RNA, Messenger; Schizophrenia | 2021 |
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
Topics: Adult; Cognition Disorders; Creatinine; Cross-Sectional Studies; Dronabinol; Female; Humans; Male; Marijuana Abuse; Neuropsychological Tests; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Self Report; Statistics, Nonparametric; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2017 |
Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior.
Topics: Brain; Cannabidiol; Cannabis; Cognition; Dronabinol; Humans; Schizophrenia | 2017 |
Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
Topics: Animals; Animals, Newborn; Dronabinol; Drug Synergism; Female; Hallucinogens; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Phencyclidine; Psychomotor Performance; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2017 |
Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.
Topics: Adult; Brain; Brain Mapping; Comorbidity; Dronabinol; Female; Humans; Magnetic Resonance Imaging; Male; Marijuana Abuse; Memory, Short-Term; Neural Pathways; Pilot Projects; Psychotropic Drugs; Rest; Schizophrenia; Schizophrenic Psychology | 2018 |
Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.
Topics: Animals; Biomarkers; Brain Waves; Cognition; Dopamine; Dronabinol; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Memory; Neurons; Prefrontal Cortex; Psychotropic Drugs; Pyramidal Cells; Rats; Receptors, GABA-A; Schizophrenia; Schizophrenic Psychology | 2017 |
THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.
Topics: Autistic Disorder; Base Sequence; Dronabinol; Gene Expression Profiling; Gene Expression Regulation; Glutamic Acid; Humans; Induced Pluripotent Stem Cells; Intellectual Disability; Mental Disorders; Mitochondria; Neurons; Post-Synaptic Density; Schizophrenia; Transcriptome | 2018 |
Different pharmaceutical preparations of Δ
Topics: Animals; Behavior, Animal; Brain; Cannabinoid Receptor Agonists; Disease Models, Animal; Dosage Forms; Dronabinol; Lipids; Locomotion; Pharmaceutical Solutions; Prepulse Inhibition; Rats; Reflex, Startle; Schizophrenia; Solubility; Solvents | 2020 |
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats.
Topics: Animals; Behavior Observation Techniques; Cerebrovascular Circulation; Circle of Willis; Disease Models, Animal; Dronabinol; Female; Hippocampus; Humans; Magnetic Resonance Angiography; Male; Methylazoxymethanol Acetate; Neurogenesis; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia; Sensorimotor Cortex | 2019 |
Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; CA3 Region, Hippocampal; Clozapine; Conditioning, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Evoked Potentials, Auditory; Humans; Male; Marijuana Abuse; Mice; Mice, Inbred DBA; Models, Animal; Psychotropic Drugs; Schizophrenia; Sensory Gating | 2014 |
Animals with a schizophrenia-like phenotype are differentially sensitive to the motivational effects of cannabinoid agonists in conditioned place preference.
Topics: Amphetamine; Animals; Avoidance Learning; Benzoxazines; Cannabinoid Receptor Agonists; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Hippocampus; Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Rats, Sprague-Dawley; Schizophrenia; Space Perception | 2014 |
Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC.
Topics: Administration, Oral; Adult; Brain; Brain Mapping; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Female; Humans; Magnetic Resonance Imaging; Male; Marijuana Smoking; Neural Pathways; Pilot Projects; Rest; Reward; Schizophrenia; Substance-Related Disorders | 2014 |
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: a brain stimulation reward study.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Benzoxazines; Brain; Brain Injuries; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dronabinol; Female; Hippocampus; Male; Morpholines; Motivation; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reward; Schizophrenia; Self Administration; Time Factors | 2014 |
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.
Topics: Animals; Antipsychotic Agents; Cannabinoids; CHO Cells; Cricetulus; Dronabinol; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology | 2015 |
High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
Topics: Cannabidiol; Cannabis; Causality; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2015 |
Need for a comprehensive national survey of cannabis use.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 2015 |
The cannabis experiment.
Topics: Adolescent; Appetite; Biomedical Research; Cannabis; Child; Colorado; Confounding Factors, Epidemiologic; Dronabinol; Humans; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Multiple Sclerosis; Netherlands; New Zealand; Prevalence; Schizophrenia; Seizures; Sweden; Young Adult | 2015 |
Perspective: Be clear about the real risks.
Topics: Cannabis; Disease Progression; Dronabinol; Humans; Mental Health; Pharmacogenetics; Risk; Schizophrenia | 2015 |
THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
Topics: Animals; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Dronabinol; Endocannabinoids; Hippocampus; Male; Phencyclidine; Polyunsaturated Alkamides; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Up-Regulation | 2016 |
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Cannabidiol; Catalepsy; Dronabinol; Hypothermia; Interpersonal Relations; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pain Measurement; Photoperiod; Psychotropic Drugs; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Time Factors | 2010 |
A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.
Topics: Animals; Disease Models, Animal; Dronabinol; Exploratory Behavior; Female; Genotype; Heterozygote; Maze Learning; Memory; Mice; Mice, Mutant Strains; Motor Activity; Neuregulin-1; Reflex, Startle; Schizophrenia; Social Behavior | 2010 |
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dronabinol; Drug Tolerance; Exploratory Behavior; Genotype; Heterozygote; Male; Mice; Mice, Mutant Strains; Motor Activity; Neuregulin-1; Proto-Oncogene Proteins c-fos; Psychotropic Drugs; Reflex, Startle; Schizophrenia | 2011 |
Neurological soft signs in non-psychotic patients with cannabis dependence.
Topics: Adolescent; Adult; Age of Onset; Analysis of Variance; Cannabinoid Receptor Agonists; Case-Control Studies; Central Nervous System Diseases; Cerebellum; Dronabinol; Female; Humans; Interview, Psychological; Male; Marijuana Abuse; Neurologic Examination; Neuropsychological Tests; Paris; Psychomotor Performance; Receptors, Cannabinoid; Schizophrenia; Substance Abuse Treatment Centers; Young Adult | 2013 |
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Topics: Adolescent; Adult; Cognition; Cognition Disorders; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Interview, Psychological; Male; Marijuana Abuse; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Siblings; Young Adult | 2012 |
The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
Topics: Animals; Animals, Newborn; Cannabidiol; Disease Models, Animal; Dronabinol; Humans; Marijuana Abuse; Mice; Psychoses, Substance-Induced; Rats; Schizophrenia | 2012 |
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Topics: Animals; Antipsychotic Agents; Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 2013 |
The effect of marijuana use on the risk for schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Alcohol Drinking; Cannabis; Causality; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Dronabinol; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Marijuana Abuse; Marijuana Smoking; Pregnancy; Psychoses, Substance-Induced; Recurrence; Risk; Schizophrenia; Schizophrenic Psychology; Social Facilitation; Telecommunications; United States; Young Adult | 2012 |
Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia.
Topics: Adult; Analysis of Variance; Autopsy; Biomarkers; Cannabinoids; Cannabis; Caudate Nucleus; Central Nervous System; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dronabinol; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Schizophrenia; Tyrosine 3-Monooxygenase | 2003 |
Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
Topics: Adult; Arachidonic Acids; Biomarkers; Brain; Cannabinoids; Cross-Sectional Studies; Dronabinol; Drug Interactions; Female; Humans; Lipid Metabolism; Male; Niacin; Nicotinic Acids; Prostaglandins; Regional Blood Flow; Schizophrenia; Skin; Skin Tests; Vasodilation | 2007 |
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.
Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Exploratory Behavior; Genotype; Hallucinogens; Male; Mice; Mice, Knockout; Motor Activity; Neuregulin-1; Psychotropic Drugs; Reflex, Startle; Schizophrenia; Social Behavior | 2007 |
Drawing conclusions about cannabis and psychosis.
Topics: Dronabinol; Humans; Marijuana Abuse; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 2008 |
Should we advise patients with serious mental illness to stop using cannabis?
Topics: Attitude of Health Personnel; Attitude to Health; Comorbidity; Counseling; Diagnosis, Dual (Psychiatry); Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Psychiatry; Psychotic Disorders; Schizophrenia | 2008 |
The coherence of the evidence linking cannabis with psychosis.
Topics: Comorbidity; Disease Susceptibility; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Risk Factors; Schizophrenia | 2008 |
Improvement in refractory obsessive compulsive disorder with dronabinol.
Topics: Adult; Cannabinoids; Comorbidity; Depressive Disorder, Major; Dronabinol; Drug Resistance; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychotropic Drugs; Schizophrenia; Treatment Outcome | 2008 |
Autonomous psychosis following psychotogenic substance abuse.
Topics: Cocaine; Dronabinol; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs; Recurrence; Risk Factors; Schizophrenia | 1995 |
Cannabis as a medicine?
Topics: Animals; Cannabis; Dronabinol; Female; Fetal Growth Retardation; Humans; Nausea; Pain; Pregnancy; Schizophrenia; Vomiting | 1995 |
Cannabis consumption as a prognostic factor in schizophrenia.
Topics: Adolescent; Adult; Comorbidity; Dronabinol; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Patient Compliance; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; Treatment Outcome | 1994 |
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.
Topics: Brain; Cannabinoids; Cannabis; Cyclohexanols; Dronabinol; Humans; In Vitro Techniques; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Schizophrenia; Substance-Related Disorders | 2001 |
Effects of marijuanna on schizophrenics.
Topics: Brain; Cannabinoids; Cannabis; Dronabinol; Humans; Schizophrenia | 1986 |